enGene Therapeutics Inc. has filed 255 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| SC 13G | 2026-07-22 | Beneficial Ownership Report (Passive) |
| 3 | 2026-07-22 | Initial Statement of Beneficial Ownership |
| 3 | 2026-07-22 | Initial Statement of Beneficial Ownership |
| 8-K | 2026-07-17 | Regulation FD Disclosure; Financial Statements and Exhibits |
| 8-K | 2026-07-16 | Departure/Appointment of Directors or Officers; Regulation FD Disclosure |
| 8-K/A | 2026-06-18 | Costs Associated with Exit or Disposal Activities; Departure/Appointment of Directors or Officers (Amended) |
| 4 | 2026-06-17 | Statement of Changes in Beneficial Ownership |
| 4 | 2026-06-17 | Statement of Changes in Beneficial Ownership |
| 4 | 2026-06-17 | Statement of Changes in Beneficial Ownership |
| 4 | 2026-06-17 | Statement of Changes in Beneficial Ownership |